Bio Retained Earnings Total Equity from 2010 to 2024

BIO Stock  USD 325.58  1.89  0.58%   
Bio Rad Retained Earnings Total Equity yearly trend continues to be very stable with very little volatility. Retained Earnings Total Equity is likely to grow to about 12 B this year. Retained Earnings Total Equity is the portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt. View All Fundamentals
 
Retained Earnings Total Equity  
First Reported
2010-06-30
Previous Quarter
10 B
Current Value
8.8 B
Quarterly Volatility
B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bio Rad financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Rad's main balance sheet or income statement drivers, such as Depreciation And Amortization of 202 M, Interest Expense of 51.9 M or Selling General Administrative of 481.6 M, as well as many indicators such as Price To Sales Ratio of 3.71, Dividend Yield of 0.0 or PTB Ratio of 2.15. Bio financial statements analysis is a perfect complement when working with Bio Rad Valuation or Volatility modules.
  
Check out the analysis of Bio Rad Correlation against competitors.

Latest Bio Rad's Retained Earnings Total Equity Growth Pattern

Below is the plot of the Retained Earnings Total Equity of Bio Rad Laboratories over the last few years. It is the portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt. Bio Rad's Retained Earnings Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Rad's overall financial position and show how it may be relating to other accounts over time.
Retained Earnings Total Equity10 Years Trend
Slightly volatile
   Retained Earnings Total Equity   
       Timeline  

Bio Retained Earnings Total Equity Regression Statistics

Arithmetic Mean5,112,163,305
Geometric Mean0.00
Coefficient Of Variation92.00
Mean Deviation4,107,502,499
Median1,836,180,000
Standard Deviation4,703,122,908
Sample Variance22119365.1T
Range13.5B
R-Value0.90
Mean Square Error4514012.9T
R-Squared0.81
Slope946,778,266
Total Sum of Squares309671111.2T

Bio Retained Earnings Total Equity History

202412 B
202311.4 B
20229.9 B
202113.5 B
20209.3 B
20195.5 B
20183.7 B

About Bio Rad Financial Statements

Bio Rad investors utilize fundamental indicators, such as Retained Earnings Total Equity, to predict how Bio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Retained Earnings Total Equity11.4 B12 B

Pair Trading with Bio Rad

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Moving against Bio Stock

  0.46FBRX Forte Biosciences TrendingPairCorr
  0.42VALN Valneva SE ADRPairCorr
  0.42VCNX VaccinexPairCorr
The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out the analysis of Bio Rad Correlation against competitors.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.412
Earnings Share
(28.06)
Revenue Per Share
90.815
Quarterly Revenue Growth
0.028
Return On Assets
0.0186
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.